Canntab Therapeutics Pill is the Way Forward for Medical Cannabis Patients

We are at the tip of the iceberg and we expect a higher valuation, says Canntab Therapeutics Limited

In this interview at the Think: Investment Mashup, SmallCapPower spoke with Richard Goldstein, CFO of Canntab Therapeutics Limited about the Company’s game changing proprietary hard tablet that improves the efficacy and absorption of medical cannabis. Canntab’s pill-based delivery mechanism allows for extended or sustained release of cannabis in the human body, lasting for a minimum of 12 to 18 hours. Mr. Goldstein also provides an update on the Company’s application to Health Canada to become a Licensed Producer (Non Grower). 

https://smallcappower.com/videos/editors-pick-video/canntab-therapeutics-cannabis-stocks/